Ephicacy, a rapidly growing biometrics contract research organization (CRO) headquartered in Iselin, announced the appointment of Jamie Powers, DrPH, as senior vice president of biometrics.
He will lead the company’s Project-Based Services (PBS) unit, including data management, biostatistics and statistical programming, and report to CEO Tara Gladwell.
Powers brings more than 23 years of experience across biostatistics, clinical analytics, AI and real-world evidence, with prior leadership roles at IQVIA, SAS Institute, ConcertAI and Takeda pharmaceutical company.
His background combines classical biostatistics and biometrics delivery experience with applied work in AI, real-world evidence and operational analytics.
“Jamie’s expertise in advanced analytics, real-world evidence and biostatistics aligns strongly with the evolving needs of modern clinical trials. His cross-industry experience will help expand our biometrics capabilities and strengthen the value we deliver to clients,” said Gladwell.
The appointment reflects Ephicacy’s continued investment in scaling biometrics and analytics capabilities as demand grows for advanced statistical programming and data science in clinical development.
Founded in 2005, Ephicacy has established itself as a leading player in the clinical analytics space, leveraging a global talent pool to help pharmaceutical and biotechnology companies reduce their time to market.
